Sugi Holdings Co (7649) AI Stock Analysis

• Market Cap: $691.52B
• Dividend Yield: 0.95%
• Average Volume (3M): 568.25K
• Price to Earnings (P/E): 16.2
• Beta (1Y): 0.17
• Revenue Growth: 20.18%
• EPS Growth: 82.36%
• Country: JP
• Employees: 8,724
• Sector: Healthcare
• Sector Strength: 40
• Industry: Medical - Pharmaceuticals
• EPS (TTM): 117.28
• Shares Outstanding: 189,992,510
• 10 Day Avg. Volume: 832,070
• 30 Day Avg. Volume: 568,246
• PEG Ratio: 7.19
• Price to Book (P/B): 2.67
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: $3,712.24
• Price Target Upside: 1.18% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 4

• Rating: 75 Outperform
• Price Target: ¥4,094.00 ▲(11.58%Upside)

Sugi Holdings Co's strong financial performance is the key driver of its overall stock score, showcasing growth, profitability, and financial stability. Technical analysis supports a bullish trend, although overbought indicators suggest caution. The valuation presents a fair investment opportunity, though not exceptionally attractive. The absence of recent earnings call insights or corporate events leaves the financial and technical analyses as the primary influences.

Sugi Holdings Co Business Overview & Revenue Model

Company Description

Sugi Holdings Co.,Ltd. operates drugstores in Japan. It also provides visiting nursing services and home care support services. As of June 1, 2019, the company operated 1,190 stores. Sugi Holdings Co.,Ltd. was founded in 1976 and is headquartered in Obu, Japan.

How the Company Makes Money

Sugi Holdings Co., Ltd. generates revenue primarily through the sale of pharmaceutical products, over-the-counter drugs, and a diverse range of health and beauty items. The company's pharmacies are strategically located to serve a broad customer base, providing both prescription fulfillment services and retail sales. Revenue streams are bolstered by its ability to attract repeat customers through loyalty programs and personalized healthcare services. Additionally, Sugi Holdings benefits from economies of scale and strong supplier relationships, which contribute to its profitability. The company also explores opportunities for expansion and diversification to drive growth, including partnerships with healthcare providers and leveraging technology to enhance customer experience.

Sugi Holdings Co Financial Statement Overview

Summary

Sugi Holdings Co exhibits a solid financial performance across all key areas. The income statement indicates strong growth and profitability, supported by efficient operations. The balance sheet reflects financial stability with a conservative debt profile. Cash flow analysis shows robust liquidity and strong cash generation. Overall, the company is well-positioned for continued growth and stability, with minimal financial risk.

Income Statement

Sugi Holdings Co has demonstrated strong revenue growth, with a notable increase in total revenue from 2024 to 2025. Gross profit margin and net profit margin have been stable, reflecting efficient cost management. EBIT and EBITDA margins are healthy, suggesting robust operational performance. The company's consistent revenue growth trajectory is a positive sign for future profitability.

Balance Sheet

The company's balance sheet reflects a strong equity position with a stable debt-to-equity ratio, indicating a conservative leverage strategy. The equity ratio is healthy, suggesting a solid financial foundation. However, there was a minor increase in total liabilities, which should be monitored for potential risks. Overall, the balance sheet suggests financial stability and low financial risk.

Cash Flow

Sugi Holdings Co has shown a strong free cash flow growth rate, indicating improved cash generation capabilities. The operating cash flow to net income ratio is stable, reflecting efficient cash management. The company has maintained a positive free cash flow to net income ratio, highlighting its ability to generate cash relative to its profitability. Cash flow trends suggest robust liquidity and financial flexibility.

Breakdown	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	878.02B	744.48B	667.65B	625.48B	602.51B
Gross Profit	275.04B	228.84B	202.52B	191.49B	181.29B
EBITDA	56.18B	46.24B	44.02B	43.41B	43.64B
Net Income	25.69B	21.98B	19.01B	19.39B	21.12B
Balance Sheet
Total Assets	495.12B	390.56B	351.89B	334.76B	345.93B
Cash, Cash Equivalents and Short-Term Investments	52.79B	47.43B	70.64B	71.83B	95.84B
Total Debt	45.35B	837.00M	1.95B	2.31B	2.33B
Total Liabilities	244.41B	157.20B	135.36B	120.87B	145.30B
Stockholders Equity	250.70B	233.36B	216.54B	213.89B	200.63B
Cash Flow
Free Cash Flow	13.31B	6.34B	16.77B	-16.20B	12.46B
Operating Cash Flow	36.94B	39.04B	38.28B	7.17B	34.03B
Investing Cash Flow	-33.28B	-30.98B	-23.26B	-23.89B	-29.25B
Financing Cash Flow	11.63B	-5.28B	-14.21B	-5.29B	-5.27B

Sugi Holdings Co Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 3669.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7649, the sentiment is Positive. The current price of 3669 is above the 20-day moving average (MA) of 3465.15, above the 50-day MA of 3276.16, and above the 200-day MA of 2827.30, indicating a bullish trend. The MACD of 141.09 indicates Negative momentum. The RSI at 66.70 is Neutral, neither overbought nor oversold. The STOCH value of 86.43 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7649.

Sugi Holdings Co Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
7649	75 Outperform	$691.52B	16.15	16.26%	0.95%	20.18%	82.36%
Sector *	52 Neutral	kr5.53B	10.86	-63.86%	2.05%	27.22%	26.17%
SDGCF	―	$3.66B	18.07	11.61%	2.68%	―	―
TSUSF	―	$3.80B	18.71	4.93%	3.29%	―	―
3549	76 Outperform	¥423.01B	22.95		0.35%	14.79%	35.84%
3141	74 Outperform	¥540.15B	29.43		1.39%	7.43%	-24.81%
3349	70 Neutral	¥729.21B	23.44		0.76%	6.96%	18.31%

Sugi Holdings Co Corporate Events

Sugi Holdings Reports Strong Sales Growth in June 2025

Sugi Holdings Co., Ltd. reported a 4.7% increase in sales for existing stores in June 2025, with the drugstore business growing by 2.9% and the prescription business by 11.8%. On an all-store basis, sales rose by 17.0%, driven by a 6.9% increase in the drugstore segment and a significant 57.6% rise in prescription sales. The company opened 8 new stores and closed 10, resulting in a total of 2,204 stores by the end of June, reflecting its strategic adjustments in the market.

The most recent analyst rating on (JP:7649) stock is a Hold with a Yen2850.00 price target. To see the full list of analyst forecasts on Sugi Holdings Co stock, see the JP:7649 Stock Forecast page.

Sugi Holdings Revises Financial Forecasts Upward Amid Strong Sales

Sugi Holdings Co., Ltd. has revised its financial forecasts for the fiscal year ending February 2026, following increased sales in the first quarter and the recording of additional deferred tax assets. The upward revision reflects a positive outlook on net sales, operating profit, and ordinary profit, driven by a merger within its subsidiaries and a strategic focus on capturing market demand.

The most recent analyst rating on (JP:7649) stock is a Hold with a Yen2850.00 price target. To see the full list of analyst forecasts on Sugi Holdings Co stock, see the JP:7649 Stock Forecast page.

Sugi Holdings Reports Strong Financial Growth for Q1 2025

Sugi Holdings Co., Ltd. reported a significant increase in its financial performance for the three months ended May 31, 2025, with net sales rising by 22.1% and profit attributable to owners of the parent increasing by 246.6% compared to the previous year. The company also revised its consolidated earnings forecast for the fiscal year ending February 28, 2026, reflecting a positive outlook despite the exclusion of I&H Co., Ltd. following an absorption-type merger with Sugi Pharmacy Co., Ltd.

The most recent analyst rating on (JP:7649) stock is a Hold with a Yen2850.00 price target. To see the full list of analyst forecasts on Sugi Holdings Co stock, see the JP:7649 Stock Forecast page.

SUGI Holdings Completes Treasury Stock Disposition

SUGI Holdings Co., Ltd. has completed the payment procedures for the disposition of treasury stock as restricted stock remuneration, a decision made by its Board of Directors on May 27, 2025. This move involves the distribution of 7,044 shares of common stock to various directors and executive officers, amounting to a total disposition value of 22,195,644 yen, potentially impacting the company’s financial strategy and stakeholder interests.

The most recent analyst rating on (JP:7649) stock is a Hold with a Yen2850.00 price target. To see the full list of analyst forecasts on Sugi Holdings Co stock, see the JP:7649 Stock Forecast page.

SUGI Holdings Maintains Independence Amid Significant Shareholder Ownership

SUGI Holdings Co., Ltd. has disclosed information regarding Sugi Shoji Co., Ltd., which holds 37.43% of its voting rights. Despite this significant ownership, Sugi Shoji does not impose any restrictions on SUGI Holdings’ business activities, and there are no plans to change this arrangement, ensuring stability in the company’s operations and management.

The most recent analyst rating on (JP:7649) stock is a Hold with a Yen2850.00 price target. To see the full list of analyst forecasts on Sugi Holdings Co stock, see the JP:7649 Stock Forecast page.

SUGI Holdings Announces Treasury Stock Disposition for Executive Incentives

SUGI Holdings Co., Ltd. has announced a resolution to dispose of 7,044 shares of its treasury stock as part of its restricted stock remuneration system. This initiative aims to incentivize directors and executive officers to enhance corporate value and align their interests with shareholders. The move is expected to strengthen the company’s governance and motivate key personnel by tying their compensation to the company’s stock performance.

The most recent analyst rating on (JP:7649) stock is a Hold with a Yen2850.00 price target. To see the full list of analyst forecasts on Sugi Holdings Co stock, see the JP:7649 Stock Forecast page.